Stanford Graduate School of Business (USA)
-
Invitrogen (A)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209A-EStrategyFounded in 1987, Invitrogen was one of the largest catalog life science companies in the industry. Its customers came from academic research, biotechnology and pharmaceutical companies and government laboratories. Scientists viewed Invitrogen as a one-stop shop for all major molecular biology, biochemistry and cell culture reagent products, with prices ranging from a hundred dollars to a few thousand dollars.Starting at €8.20
-
Invitrogen/Life Technologies (B)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209B-EStrategyOn June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share’s closing price on Wednesday, June 11, 2008.Starting at €5.74
-
Good Ventures: The Power of Informed Decisions
Laura Arrillaga-Andreessen, Sarah MurrayCase SGSB-SI124-EBusiness Ethics and Corporate Social Responsibility, Innovation and ChangeIn 2010, Cari Tuna quit her job at the Wall Street Journal to work full-time on developing a giving strategy for herself and her husband—Facebook co-founder Dustin Moskovitz. In May 2011, the couple created the philanthropic foundation Good Ventures. Tuna made transparency and knowledge sharing core components of the foundation; creating a blog to report on the foundation’s activities and learnings. Good Ventures co-funded projects so that the...Starting at €8.20
-
Palantir Philanthropy Engineering: Software to Improve Lives
Laura Arrillaga-Andreessen, Sarah MurrayCase SGSB-SI125-EBusiness Ethics and Corporate Social Responsibility, Innovation and ChangeBy 2014, Palantir Technologies, a fast growing Silicon Valley company with global impact at the heart of its mission, had spent several years donating the same software to nonprofits that it sold to commercial customers to help solve some of the world’s most pressing problems. It had consolidated these philanthropic activities in 2011, when Jason Payne, a long-time software engineer at the company, made an internal transition to found the compan...Starting at €8.20
-
Good Ventures: The Power of Informed Decisions - Teaching Note
Laura Arrillaga-Andreessen, Sarah MurrayTeaching Note SGSB-SI124TN-EBusiness Ethics and Corporate Social Responsibility, Innovation and ChangeIn 2010, Cari Tuna quit her job at the Wall Street Journal to work full-time on developing a giving strategy for herself and her husband—Facebook co-founder Dustin Moskovitz. In May 2011, the couple created the philanthropic foundation Good Ventures. Tuna made transparency and knowledge sharing core components of the foundation; creating a blog to report on the foundation’s activities and learnings. Good Ventures co-funded projects so that the...Starting at €0.00
-
Palantir Philanthropy Engineering: Software to Improve Lives - Teaching Note
Laura Arrillaga-Andreessen, Sarah MurrayTeaching Note SGSB-SI125TN-EBusiness Ethics and Corporate Social Responsibility, Innovation and ChangeBy 2014, Palantir Technologies, a fast growing Silicon Valley company with global impact at the heart of its mission, had spent several years donating the same software to nonprofits that it sold to commercial customers to help solve some of the world’s most pressing problems. It had consolidated these philanthropic activities in 2011, when Jason Payne, a long-time software engineer at the company, made an internal transition to found the compan...Starting at €0.00
-
Invitrogen/Life Technologies (C): The "Best Owner" of the Asset
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209C-EStrategyThis short case discusses the process of Life Technologies’ acquisition by Thermo Fisher in 2013 and 2014. The case is a complement to SM-209A and SM-209B, which highlight the various growth and acquisition strategies the company undertook over the previous 10 years.Starting at €5.74